secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARTELO BIOSCIENCES, INC. (ARTL)
CIK:        0001621221
Form:       8-K
Filed at:   2021-12-07T23:59:59+00:00
Accession:  0001640334-21-003064
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Artelo Biosciences grants CEO Gregory Gorgas option for 1.355M shares at $0.63
------------------------------------------------------------------------------

- Option to purchase 1,355,000 shares of common stock at exercise price of $0.63 per share.
- Granted on December 3, 2021 under the 2018 Equity Incentive Plan.
- Vesting: 25% on December 3, 2022; remaining shares vest ratably monthly over 36 months.
- Continued service as a Service Provider required for vesting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621221/000164033421003064/0001640334-21-003064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621221/000164033421003064/artl_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-21-003064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer